HOW CAN WE HELP YOU? Call 1-800-TRY-CHOP
81 - 90 of 188
ICON 3 is a prospective, open label, randomized, multi-center phase 3 clinical trial comparing eltrombopag with the enrolling physician’s choice of front line therapy.
This study is looking to recruit CHOP patients 5-30 years old with suspected/ confirmed bone sarcomas. The study is looking to evaluate a new MRI technique to evaluate bones and any mass in them.
The purpose of this research study is to examine relationships between brain and behavior development in toddlers with and without autism who have older siblings.
In this study, we are developing new magnetic resonance imaging (MRI) and ultrasound methods to determine if it is effective in diagnosing complication in kidney transplant patients.
The goal of this study is to track the early development of infants with an older sibling, so we can better understand how autism develops.
The purpose of this research study is to collect information over time in juvenile SpA and back pain patients.
This study will take the patients white blood cells - T cells - and change them to turn against the cancer.
The Philadelphia Coalition for a Cure (PC4C) study is interested in collecting blood and saliva samples from you, as well as leftover tissue and cerebrospinal fluid from surgeries at CHOP.
The Children's Hospital of Philadelphia is conducting a Natural History Study in Leigh Syndrome.
While recent research has demonstrated that whole genome sequencing is a powerful first-line diagnostic tool, important questions remain around its long-term impact on downstream clinical management approaches.